ReferIndia News Aurobindo pharma receives USFDA nod for two Dapagliflozin tablets

ReferIndia News

Mumbai’s Trusted Investment Experts

24+ years of financial planning, portfolio management & wealth growth.

Learn More
News Image

Aurobindo pharma receives USFDA nod for two Dapagliflozin tablets

Published on: April 7, 2026, 11 p.m. | Source: Times of India

India Business News: HYDERABAD: Aurobindo Pharma on Tuesday said it has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market .

Checkout more news
Ad Banner

Kunjesh Investment Banking – Trusted Since 2001

Financial Planning • Insurance • Investments • Retirement & Wealth Management. Personalized strategies, expert guidance, lasting success.

Get Started
ReferIndia News contact